Genesys International Corp fixes rights issue price at ₹50 for 2.5Cr shares
Genesys International Corporation Limited has confirmed the terms of its rights issue, approving the sale of 2,50,74,226 shares at ₹50 each to raise up to ₹12,537.11 lakhs. The record date is set for August 06, 2026, with an entitlement ratio of 3:5.

*this image is generated using AI for illustrative purposes only.
Genesys International Corporation Limited company name has finalized the key terms of its equity rights issue, setting the subscription price at ₹50 per share and targeting a raise of up to ₹12,537.11 lakhs. The Rights Issue Committee approved these details on July 31, 2026, confirming an offer of 2,50,74,226 fully paid-up equity shares to existing shareholders. This capital raise aims to strengthen the company’s balance sheet, with the record date fixed for August 06, 2026, determining eligibility for participation.
The decision follows initial board approval in June and in-principle clearance from both BSE Limited and the National Stock Exchange of India Ltd. received on July 27, 2026. The committee’s meeting concluded with a definitive structure for the issuance, including the entitlement ratio and timeline for subscription. Shareholders holding stock on the record date will receive rights to purchase new shares at a premium of ₹45 over the face value of ₹5.
Key Terms of the Rights Issue
The finalized parameters define the mechanics of the offer, ensuring clarity for eligible investors regarding their entitlements and the subscription window.
| Parameter | Detail |
|---|---|
| Issue Size | Up to ₹12,537.11 lakhs (2,50,74,226 shares) |
| Issue Price | ₹50 per share (₹45 premium over ₹5 face value) |
| Entitlement Ratio | 3 new shares for every 5 existing shares held |
| Record Date | August 06, 2026 |
| Opening Date | August 14, 2026 |
| Closing Date | August 21, 2026 |
Entitlement and Fractional Share Rules
Eligibility is determined by holdings as of the record date. The company has specified strict rules for fractional entitlements to ensure fair distribution. Holdings less than five shares or not in multiples of five will result in ignored fractional entitlements. However, these shareholders may receive preferential consideration for one additional share if they apply for shares beyond their rights entitlement, subject to availability.
Shareholders with fewer than five shares have zero entitlement but can apply for additional shares, receiving preference for one extra share if available. These applications are non-negotiable and cannot be renounced to third parties. The ISIN for dematerialized rights entitlement is INE727B20018.
Capital Structure Impact
The rights issue will significantly expand the company’s outstanding equity base. Prior to the issuance, Genesys had 4,17,90,377 fully paid-up equity shares. Assuming full subscription, the post-issue capital structure will comprise 6,68,64,603 shares. This expansion dilutes existing ownership percentages but provides the company with substantial fresh capital for operational needs or debt reduction.
What the Numbers Show
The pricing at ₹50 represents a significant premium over the ₹5 face value, indicating management’s confidence in the company’s intrinsic value and future prospects. The ability to raise over ₹12,500 lakhs through a rights issue suggests strong shareholder support and liquidity in the market. The structured approach to fractional entitlements minimizes administrative complexity while offering limited recourse to small holders, balancing efficiency with fairness.
Regulatory Compliance and Next Steps
The disclosure was made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Kushal Jain, Company Secretary & Compliance Officer, signed the notice submitted to both stock exchanges. The issue window opens on August 14, 2026, with an on-market renunciation period running until August 18, 2026. The closing date is August 21, 2026, though the Board retains the right to extend this by up to 30 days from the opening date if necessary.
Historical Stock Returns for Genesys International Corp
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -5.71% | -24.91% | -25.16% | -14.31% | -57.34% | +87.80% |
How will the ₹12,537.11 lakh capital raise specifically impact Genesys International's debt-to-equity ratio and interest coverage ratios in the upcoming fiscal year?
What specific operational expansions or strategic acquisitions is Genesys International planning to fund with this fresh equity capital?
How might the 3:5 entitlement ratio and ₹50 subscription price influence short-term trading volume and price volatility during the renunciation period ending August 18, 2026?


































